drugset / Trial / NCT00913029

Evaluation of the iStent Versus Two Ocular Hypotensive Agents in Patients With Primary Open-angle Glaucoma (POAG)

NCT00913029 ↗

Phase 4 Completed 192 enrolled Glaukos Corporation
RandomizedParallel-groupOpen-labelTreatment

Summary

Prospective, unmasked, randomized evaluation of the iStent in patients with primary open-angle glaucoma. Patients will be randomized to one of two groups: 1) iStent, or 2) medication.

Timeline

Start
2009-05
Primary completion
2012-09
Completion
2012-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator latanoprost/timolol Unknown — —

Indications